The S&P 500 edged up 0.6% on Monday, March 17, after a report showed retail sales recovered in February but fell short of ...

This therapy targets multiple tumor-specific antigens, offering improved treatment precision for blood cancer patients, and significantly reducing costs, thus enhancing accessibility in India and ...

Chance Pharmaceuticals ("Chance Pharma"), a clinical-stage biotechnology company dedicated to the research and development of innovative inhalation therapies, today announced the successful completion ...

HARARE, March 15 (Xinhua) -- The Zimbabwean government said Friday that it will boost health funding to cover a gap left by the reduction of U.S. support.

Informa Connect Medical Division announces landmark Geneva-based conference, convening the world's foremost industry leaders ...

Rentosertib is designed to treat IPF by targeting Traf2- and NCK-interacting kinase (TNIK), a serine/threonine kinase whose activation plays a crucial role in cellular processes that include signal ...

In a transaction officially set to close later this month, Syngene International Limited, a contract research, development, ...

TAIPEI, Taiwan, March 13, 2025 (GLOBE NEWSWIRE) -- New-generation Contract Development and Manufacturing Organization (CDMO) ...

Accomplished Technology Executive and Entrepreneur Wensheng Fan Joins DeepRx Inc. PITTSBURGH, PENNSYLVANIA / ACCESS Newswire / March 11, 2025 / DeepRx Inc., a predictive analytics company advancing AI ...

Athletics New Zealand is proud to announce an historic contingent of 12 athletes who will compete at the World Athletics ...